These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Disseminated sclerosis among migrants: an attempt at supporting the viral etiology]. Cendrowski W Pol Tyg Lek; 1974 Apr; 29(16):677-9. PubMed ID: 4597163 [No Abstract] [Full Text] [Related]
25. Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections. Poskanzer DC; Sever JL; Sheridan JL; Prenney LB J Epidemiol Community Health; 1980 Dec; 34(4):258-64. PubMed ID: 7241024 [TBL] [Abstract][Full Text] [Related]
26. Rickettsial and viral antibodies in multiple sclerosis. ROSS CA Br Med J; 1962 Jun; 1(5291):1523-4. PubMed ID: 14494149 [No Abstract] [Full Text] [Related]
27. [Polyspecific immune reaction in the central nervous system in autoimmune diseases with CNS involvement]. Graef IT; Henze T; Reiber H Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):587-91. PubMed ID: 7856266 [No Abstract] [Full Text] [Related]
28. Association of chronic progressive neurological disease and ubiquitous viral agents: lessons from human herpesvirus 6 and multiple sclerosis. Fogdell-Hahn A; Soldan SS; Jacobson S Mol Psychiatry; 2002; 7 Suppl 2():S29-31. PubMed ID: 12142941 [No Abstract] [Full Text] [Related]
29. [Etiopathogenic hypotheses of multiple sclerosis]. Caputo D; Zibetti A; Ghezzi A; Di Costanzo M Arch Sci Med (Torino); 1980; 137(4):673-7. PubMed ID: 6941748 [No Abstract] [Full Text] [Related]
31. Symposium on etiology, diagnosis and treatment of multiple sclerosis. Recent concepts of etiology: implications for treatment. Silberberg DH Mod Treat; 1970 Sep; 7(5):879-89. PubMed ID: 4933353 [No Abstract] [Full Text] [Related]
32. [Will multiple sclerosis, psoriasis and rheumatoid arthritis disappear?]. Král M Cesk Neurol Neurochir; 1986 Sep; 49(5):329-31. PubMed ID: 3779872 [No Abstract] [Full Text] [Related]
33. An introduction to the possible connection of multiple sclerosis with a virus infection. Panelius M Ann Clin Res; 1973 Oct; 5(5):316-8. PubMed ID: 4792207 [No Abstract] [Full Text] [Related]
34. [Role of immune mechanisms in the pathogenesis of disseminated sclerosis]. D'iakonova IN; Matveeva TV Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):66-70. PubMed ID: 6979141 [No Abstract] [Full Text] [Related]
35. Recent advance in the study of multiple sclerosis. Igata A Tokai J Exp Clin Med; 1986; 11 Suppl():171-7. PubMed ID: 2898174 [No Abstract] [Full Text] [Related]
36. [Human herpesvirus 6 and multiple sclerosis]. Piédrola Angulo G An R Acad Nac Med (Madr); 2005; 122(2):377-89; discussion 389-92. PubMed ID: 16463579 [TBL] [Abstract][Full Text] [Related]
37. Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy. Rice GP; Armstrong HA; Bulman DE; Paty DW; Ebers GC Ann Neurol; 1986 Oct; 20(4):533-4. PubMed ID: 2878638 [TBL] [Abstract][Full Text] [Related]
38. Measles virus antibodies in multiple sclerosis. Cendrowski W; Niedzielska K Acta Med Pol; 1974; 15(4):189-202. PubMed ID: 4140677 [No Abstract] [Full Text] [Related]
39. Investigation on the role of viral antibodies in the pathogenesis of multiple sclerosis. Matveeva TV; Pille ER; Diakonova IN; Andreeva AP Acta Virol; 1980 Dec; 24(6):415-20. PubMed ID: 6111202 [TBL] [Abstract][Full Text] [Related]
40. Virus antibodies in patients with multiple sclerosis. Salmi AA Ann Clin Res; 1973 Oct; 5(5):319-29. PubMed ID: 4365526 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]